Centene Corporation $CNC Shares Sold by Thompson Siegel & Walmsley LLC

Thompson Siegel & Walmsley LLC trimmed its position in Centene Corporation (NYSE:CNC) by 4.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 1,618,417 shares of the company’s stock after selling 76,832 shares during the quarter. Centene comprises approximately 1.1% of Thompson Siegel & Walmsley LLC’s investment portfolio, making the stock its 20th biggest holding. Thompson Siegel & Walmsley LLC’s holdings in Centene were worth $66,598,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in CNC. Addison Advisors LLC lifted its position in shares of Centene by 455.6% during the 3rd quarter. Addison Advisors LLC now owns 739 shares of the company’s stock valued at $26,000 after acquiring an additional 606 shares during the last quarter. SBI Securities Co. Ltd. lifted its position in shares of Centene by 118.4% during the 4th quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock valued at $31,000 after acquiring an additional 406 shares during the last quarter. Ameriflex Group Inc. lifted its position in shares of Centene by 152.5% during the 3rd quarter. Ameriflex Group Inc. now owns 1,010 shares of the company’s stock valued at $36,000 after acquiring an additional 610 shares during the last quarter. GoalVest Advisory LLC acquired a new stake in shares of Centene during the 4th quarter valued at $37,000. Finally, Union Bancaire Privee UBP SA acquired a new stake in shares of Centene during the 4th quarter valued at $37,000. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Trading Up 0.2%

NYSE CNC opened at $59.72 on Monday. Centene Corporation has a 1-year low of $25.08 and a 1-year high of $60.76. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.76. The company has a market capitalization of $29.49 billion, a PE ratio of -4.54, a price-to-earnings-growth ratio of 0.47 and a beta of 1.09. The firm’s fifty day simple moving average is $45.44 and its 200-day simple moving average is $42.47.

Centene (NYSE:CNC) last posted its quarterly earnings results on Tuesday, April 28th. The company reported $3.37 earnings per share for the quarter, topping analysts’ consensus estimates of $2.23 by $1.14. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. The business had revenue of $49.94 billion for the quarter, compared to the consensus estimate of $47.53 billion. During the same period in the prior year, the business posted $2.90 earnings per share. Centene’s revenue for the quarter was up 7.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that Centene Corporation will post 3.45 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

CNC has been the subject of a number of recent research reports. UBS Group reiterated a “neutral” rating and set a $61.00 price objective (up from $55.00) on shares of Centene in a research report on Friday, May 22nd. Jefferies Financial Group boosted their target price on shares of Centene from $39.00 to $48.00 and gave the company a “hold” rating in a research note on Wednesday, April 29th. Cantor Fitzgerald raised shares of Centene from a “neutral” rating to an “overweight” rating and boosted their target price for the company from $41.00 to $60.00 in a research note on Tuesday, April 28th. Robert W. Baird boosted their target price on shares of Centene from $36.00 to $37.00 and gave the company a “neutral” rating in a research note on Wednesday, April 15th. Finally, Morgan Stanley boosted their target price on shares of Centene from $45.00 to $50.00 and gave the company an “equal weight” rating in a research note on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, Centene presently has an average rating of “Hold” and a consensus price target of $58.18.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.